Certified by Founder Lodge
Be Biopharma
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $82,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Be Bio is pioneering Engineered B Cell Medicines (BCMs) to dramatically improve the lives of patients who are living with Hemophilia B and other genetic diseases, cancer, and other serious co
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 23 ,2024 | Unknown | $82,000,000 | |
| January, 16 ,2025 | Series C | $92,000,000.00 |
ARCH Venture Partners
Atlas Venture
RA Capital Management, L.P.
Takeda Ventures, Inc.
Bristol Myers Squibb
Longwood Fund
Alta Partners
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Athenic AI | $4,300,000 | (Jan 31, 2025)
Medsender | $5,000,000 | (Jan 31, 2025)
Seraphic Security | $29,000,000 | (Jan 31, 2025)
Freeze | $2,600,000 | (Jan 31, 2025)
Final Round AI | $6,880,000 | (Jan 31, 2025)
